Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 18 , ISSUE 5 ( May, 2014 ) > List of Articles


Evaluation of rationality in prescribing, adherence to treatment guidelines, and direct cost of treatment in intensive cardiac care unit: A prospective observational study

Rohan P. Christian, Devang A. Rana, Supriya D. Malhotra, Varsha J. Patel

Keywords : Acute coronary syndrome, direct treatment cost, drug utilization, intensive cardiac care unit

Citation Information : Christian RP, Rana DA, Malhotra SD, Patel VJ. Evaluation of rationality in prescribing, adherence to treatment guidelines, and direct cost of treatment in intensive cardiac care unit: A prospective observational study. Indian J Crit Care Med 2014; 18 (5):278-280.

DOI: 10.4103/0972-5229.132482

License: CC BY-ND 3.0

Published Online: 01-05-2014

Copyright Statement:  Copyright © 2014; The Author(s).


Background: Cardiovascular diseases (CVDs) remain the most common cause of sudden death. Hence, appropriate drug therapy in intensive cardiac care unit (ICCU) is crucial in managing cardiovascular emergencies and to decrease morbidity and mortality. Objective: To evaluate prescribing pattern of drugs and direct cost of therapy in patients admitted in ICCU. Materials and Methods: Patients admitted in ICCU of a tertiary care teaching hospital were enrolled. Demographic data, clinical history, and complete drug therapy received during their stay in ICCU were noted. Data were analyzed for drug utilization pattern and direct cost of treatment calculated using patient′s hospital and pharmacy bills. Rationality of therapy was evaluated based on American College of Cardiology/American Heart Association (ACC/AHA) guidelines. Result: Data of 170 patients were collected over 2 months. Mean age of patients was 54.67 ± 13.42 years. Male to female ratio was 2.33:1. Most common comorbid condition was hypertension 76 (44.7%). Most common diagnosis was acute coronary syndrome (ACS) 49.4%. Mean stay in ICCU was 4.42 ± 1.9 days. Mean number of drugs prescribed per patient was 11.43 ± 2.85. Antiplatelet drugs were the most frequently prescribed drug group (86.5%). Mean cost of pharmacotherapy per patient was `2701.24 ± 3111.94. Mean direct cost of treatment per patient was ₹0564.74 ± 14968.70. Parenteral drugs constituted 42% of total drugs and 90% of total cost of pharmacotherapy. Cost of pharmacotherapy was positively correlated with number of drugs (P = 0.000) and duration of stay (P = 0.027). Conclusion: Antiplatelet drugs were the most frequently prescribed drug group. Mean number of drugs per encounter were high, which contributed to the higher cost of pharmacotherapy. ACC/AHA guidelines were followed in majority of the cases.

PDF Share
  1. Gaziano TA, Gaziano JM. Epidemiology of cardiovascular diseases. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison′s Principles of Internal Medicine. 18 th ed. McGraw Hill; 2012. p. 1811-6.
  2. Epidemiology of Cardiovascular Disease- Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Available from: Epidemiology of Cardiovascular Disease [Last cited on 2013 Aug 13].
  3. Cardiovascular diseases in India-Challenges and way ahead. Available from: [Last cited on 2013 Aug 13].
  4. Rissam HS, Kishore SN. Trehan coronary artery disease in young Indians - The missing link. J Indian Acad Clin Med 2001;3:128-32.
  5. Bahl VK, Prabhakaran D, Karthikeyan G. Coronary artery disease in Indians. Indian Heart J 2001;53:707-13.
  6. Okrainec K, Banerjee DK, Eisenberg MJ. Coronary artery disease in the developing world. Am Heart J 2004;148:7-15.
  7. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601.
  8. Kutz JN, Becker RC. Evolution of the Coronary Care Unit: Past, Present, and Future. In: Jeremias A, Brown DL, editors. Cardiac Intensive Care. 2 nd ed. Philadelphia: Elsevier Publication; 2010. p . 1-8
  9. O′Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al., CF/AHA Task Force. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:529-55.
  10. O′Connor RE, Brady W, Brooks SC, Diercks D, Egan J, Ghaemmaghami C, et al. Part 10: Acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010;122:S787-817.
  11. Weintraub NL, Collins SP, Pang PS, Levy PD, Anderson AS, Arslanian-Engoren C, et al., American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Acute heart failure syndromes: Emergency department presentation, treatment, and disposition: Current approaches and future aims: A scientific statement from the American Heart Association. Circulation 2010;122:1975-96.
  12. Introduction to Drug Utilization Research. Available from:[Last cited on 2013 Aug 13].
  13. Patel BJ, Patel KH, Trivedi HR. Drug utilization study in intensive coronary care unit of a tertiary care teaching hospital. NJIRM 2012;3:28-33.
  14. Wal P, Wal A, Nair VR, Rai AK, Pandey U. Management of coronary artery disease in a Tertiary Care Hospital. J Basic Clin Pharm 2013;4:31-5.
  15. National List of Essential Medicines of India. Available from: http://www. List of Essential Medicine- final copy.pdf [Last accessed on 2013 Aug 13].
  16. WHO Model Lists of Essential Medicines-2011. Available from: [Last cited on 2013 Aug 13].
  17. Malik A, Malik S. Indian drug review compendium. 1 st ed. New Delhi: Mediworld Publications; 2012.
  18. CIMS Asia. Available from:[Last cited on 2013 Aug 13].
  19. Al-Junid SM, Ezat WP, Surianti S. Prescribing patterns and drug cost among cardiovascular patients in Hospital Universiti Kebangsaan Malaysia. Med J Malaysia 2007;62:59-65.
  20. Hod H, Gotlieb S, Green M, Hammerman H, Zahger D, Hasdai D, et al. Trends in management, morbidity and mortality of patients with acute myocardial infarction hospitalized in the last decade. Harefuah 2006;145:326-31, 400.
  21. Manurung D. Lipid profiles of acute coronary syndrome patients hospitalized in ICCU of Cipto Mangunkusumo Hospital. Acta Med Indones 2006;38:196-201.
  22. Valente S, Lazzeri C, Sori A, Giglioli C, Bernardo P, Gensini GF. The recent evolution of coronary care units into intensive cardiac care units: The experience of a tertiary center in Florence. J Cardiovasc Med (Hagerstown) 2007;8:181-7.
  23. Patel VK, Acharya LD, Rajakannan T, Surulivelrajan M, Guddattu V, Padmakumar R. Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital. Australas Med J 2011;4:9-14.
  24. Richard FG. The ongoing regulation of generic drugs. N Engl J Med 2007;357:1993-6.
  25. Shankar R, Partha P, Shenoy N. Prescribing Patterns of drugs among patients admitted with cardiovascular disorders in the internal medicine ward: Prescribing patterns in inpatients. Internet J Pharmacol 2001;1. Available from: [Last cited on 2013 Aug 13].
  26. Drug Interactions Checker from Available from: [Last cited on 2013 Aug 13].
  27. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention for of surgical site infection; 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999;27:97-132. Available from: [ 1999.pdf [Last cited on 2013 Aug 13].
  28. Singh H, Houy TL, Singh N, Sekhon S. Gastrointestinal prophylaxis in critically ill patients. Crit Care Nurs Q 2008;31:291-301.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.